z-logo
open-access-imgOpen Access
Letter by Chen et al Regarding Article, “Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial”
Author(s) -
Zhiqing Chen,
Feng Chen,
Lang Li
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.120.046310
Subject(s) - medicine , dapagliflozin , timi , atrial fibrillation , diabetes mellitus , cardiology , type 2 diabetes mellitus , type 2 diabetes , endocrinology , myocardial infarction , thrombolysis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom